RankingsPricing
  1. JP-listed companies
  2. TRANS GENIC GROUP INC.
  3. Financials
  4. Cash and cash equivalents

TRANS GENIC GROUP INC.【JP:2342】

Market cap
¥5.3B
P/E ratio
129.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 20252,555+3.11%
Mar 31, 20242,478-28.36%
Mar 31, 20233,459-25.10%
Mar 31, 20224,619+52.42%
Mar 31, 20213,030+88.99%
Mar 31, 20201,603+25.50%
Mar 31, 20191,278-27.93%
Mar 31, 20181,773+67.35%
Mar 31, 20171,059+0.52%
Mar 31, 20161,054+11.37%
Mar 31, 2015946

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)